Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial

By Trannoy E.   Berger R.   Hollander G.   Bailleux F.   Heimendinger P.   Vuillier D.   Creusvaux H.  

Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. : 1700-1706

Elsevier

Access to resources Recommend Favorite

Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan

By Ozaki T.   Matsui Y.   Kajita Y.   Nishimura N.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2618-2622

Elsevier

Access to resources Recommend Favorite

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax(R)) in children and adults

By Krah D.L.   Cho I.   Schofield T.   Ellis R.W.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX&unknown; in healthy children

By Lau Y.-L.   Vessey S.J.R.   Chan I.S.F.   Lee T.-L.   Huang L.-M.   Lee C.-Y.   Lin T.-Y.   Lee B.W.   Kwan K.   Kasim S.M.   Chan C.Y.   Kaplan K.M.   Distefano D.J.   Harmon A.L.   Golie A.   Hartzel J.   Xu J.   Li S.   Matthews H.   Sadoff J.C.   Shaw A.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2942-2949

Elsevier

Access to resources Recommend Favorite

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax(R)) in healthy adolescents and adults

By Oka/Merck Varicella Vaccine Study Group   Kuter B.J.   Ngai A.   Patterson C.M.   Staehle B.O.   Cho I.   Matthews H.   Provost P.J.   White C.J.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 967-972

Elsevier

Access to resources Recommend Favorite